Does Thymosin Alpha-1 Help Post-Viral Fatigue and Joint Pain?

Thymosin alpha-1 has not been shown to relieve post-viral fatigue or joint pain in people. The closest research is a lab study of blood cells from 10 people with long COVID, where the peptide appeared to push their immune cells back toward a normal response. No study in the research looked at joint recovery. In the US, thymosin alpha-1 is not FDA-approved and is only available as a compounded medication, and FDA's 2024 compounding review flagged possible safety risks with compounded versions.

What is thymosin alpha-1, and why do people try it after a virus?

Thymosin alpha-1 is a peptide, a short chain of 28 amino acids, made by the thymus. The thymus is the gland where your T cells mature, and T cells are the immune cells that clear viruses.

It is an approved prescription drug in some countries. Singapore registers it as Zadaxin for chronic hepatitis B. The dose is 1.6 mg injected under the skin twice a week for 6 to 12 months.

Some people with long-lasting fatigue hear about it from integrative doctors and peptide forums. One person on r/Peptides said they have CIRS and ME/CFS and are mostly bedridden. Their integrative doctor suggested several peptides, including thymosin alpha-1. They wrote: "I don’t want to do anything super risky, but am also desperate to get well and have my life back."

Approval for hepatitis B tells you thymosin alpha-1 has a safety record in that use. It does not tell you it treats fatigue or joint pain. The rest of this page shows what the research covers.

What does the research show for long COVID and post-viral fatigue?

The pattern across these studies is that thymosin alpha-1 shifts immune markers in sick people. No study here shows that people with lingering fatigue felt more energetic on it. Better lab numbers and feeling better are separate results, and only the first has been studied.

Can thymosin alpha-1 help joint pain after a virus?

No study in this research tested thymosin alpha-1 for joint pain or joint recovery after a viral illness. Anyone telling you it repairs joints is going beyond the evidence.

There is also a reason for caution. According to FDA's review, labels for thymosin alpha-1 products sold outside the US carry warnings and contraindications for people with autoimmune diseases. That matters here, because joint pain that starts after a virus can sometimes be autoimmune.

If your joints are swollen, hot or stiff in the morning, tell your clinical team before you try any treatment that acts on your immune system. They can check what is driving the pain first.

Is thymosin alpha-1 safe, and can you get it in the US?

In most clinical studies, at doses of 1 to 16 mg under the skin for up to 12 months, the most common side effects were irritation, redness or discomfort where the needle went in, FDA's review notes.

The Zadaxin label says it should be considered off-limits for people whose immune systems are being deliberately suppressed, such as organ transplant patients, unless the benefits clearly outweigh the risks. FDA's review also lists flares in ALT, a liver enzyme, in people with chronic hepatitis B, and changes in TSH, a thyroid hormone, in people with chronic hepatitis C.

Compounded versions raise their own questions. FDA has said compounded thymosin alpha-1 "may pose a significant risk for immunogenicity" for certain routes of use, which means your body could form an immune reaction against the peptide itself. FDA also said the safety information is too thin for it to understand the full risk. The request to add thymosin alpha-1 to FDA's compounding list was withdrawn, and FDA kept its risk note.

In the US, thymosin alpha-1 is not FDA-approved. Online clinics offer it as a compounded injection by prescription. Promise lists a 1 mg/mL, 5 mL vial at $229 for the first shipment, then $279 every 28 days until you cancel.

Can Hot or Nothing prescribe thymosin alpha-1?

Hot or Nothing does not offer thymosin alpha-1. Our energy and aging plans include NAD+, MOTS-c, ipamorelin and CJC-1295. Our healing and recovery plans include sermorelin, BPC-157 and TB-500.

Tell your clinical team how long the fatigue has lasted, what makes it worse, which joints hurt and any blood work you already have. That gives them what they need to decide whether one of our treatments fits your goal.

Your clinical team decides whether a treatment fits your health history. If something else needs to be checked first, they will tell you.

You want your afternoons and your workouts back. Take the quiz so your clinical team can see where your energy and recovery stand and which plan fits your goal.